Search - tctmd.com

Displaying 1 - 20 of 209

Sort: Relevancy | Date

An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Presentation AHA 2016

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Presenter: Michael Gibson

November 15, 2016

Presentation AHA 2016

Arterial Revascularization Trial (ART)

Presenter: David P. Taggart

November 15, 2016

Presentation TCT 2016

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Evald H. Christiansen

October 31, 2016

Presentation TCT 2016

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Gregg W. Stone

October 31, 2016

Presentation Stanford Coronary Physiology Conference 2016

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Presenter: William F. Fearon

October 28, 2016

Presentation ESC 2016

10-year outcomes of coronary artery bypass grafting vs medical therapy according to age: An update from the STICH trial

Presenter: Eric Velazquez

August 29, 2016

Presentation

Coronary Perforation During PCI in the United Kingdom Between 2006 and 2013

Presenter: Tim Kinnaird

August 04, 2016

Presentation

Long-term Mortality After Revascularization in Nondiabetic Patients With Multivessel Disease

Presenter: Mineok Chang

June 28, 2016

Presentation TVT 2016

Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (Indications for CABG vs PCI, Hybrid Approaches, and Completeness of Revascularization)

Presenter: James B. Hermiller Jr

June 17, 2016

Presentation SOLACI 2016

Left-Main Disease: When is PCI the Preferred Strategy?

Presenter: Rafael Cavalcante

June 08, 2016

Presentation

CABG and PCI in Patients With Unprotected Left Main Coronary Artery Disease

Presenter: Zhe Zheng

June 08, 2016

Presentation

Revascularization Trends in Pts with Diabetes and Multivessel CAD Presenting with NSTEMI

Presenter: Ambarish Pandey

May 12, 2016

Presentation Fellows 2016

Left Main Disease: PCI vs CABG

Presenter: Dimitrios Karmpaliotis, Philippe Généreux

April 16, 2016

Presentation

2016 TCTMD Heart Team Survey

Presenter: 190204|Yael L. Maxwell

April 13, 2016

Presentation CHIP Florida 2016

The Modern Approach to CTO PCI: What is it and How has it changed the management of CHIP patients

Presenter: William Lombardi

April 01, 2016

Presentation CHIP Florida 2016

Calcified Anatomy: Case Review

Presenter: Nirat Beohar

April 01, 2016

Presentation

Characteristics of Patients Undergoing Cardiac Cath Prior to Noncardiac Surgery

Presenter: Schulman-Marcus

March 31, 2016

Presentation

Second- vs First-Generation DES in Multivessel Disease With Left Main Stenosis

Presenter: Carlos Haiek

March 14, 2016

Presentation

Successful Recanalization of Native Coronary CTO Is Not Associated With Improved Long-Term Survival

Presenter: Pil Hyung Lee

March 03, 2016

Presentation

Impact of Diabetes on Outcomes After PCI With DES in Relation to CAD Complexity

Presenter: KC. Koskinas

February 02, 2016

Advertisement

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Arterial Revascularization Trial (ART)

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

10-year outcomes of coronary artery bypass grafting vs medical therapy according to age: An update from the STICH trial

Coronary Perforation During PCI in the United Kingdom Between 2006 and 2013

Long-term Mortality After Revascularization in Nondiabetic Patients With Multivessel Disease

Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (Indications for CABG vs PCI, Hybrid Approaches, and Completeness of Revascularization)

Left-Main Disease: When is PCI the Preferred Strategy?

CABG and PCI in Patients With Unprotected Left Main Coronary Artery Disease

Revascularization Trends in Pts with Diabetes and Multivessel CAD Presenting with NSTEMI

Left Main Disease: PCI vs CABG

2016 TCTMD Heart Team Survey

The Modern Approach to CTO PCI: What is it and How has it changed the management of CHIP patients

Calcified Anatomy: Case Review

Characteristics of Patients Undergoing Cardiac Cath Prior to Noncardiac Surgery

Second- vs First-Generation DES in Multivessel Disease With Left Main Stenosis

Successful Recanalization of Native Coronary CTO Is Not Associated With Improved Long-Term Survival

Impact of Diabetes on Outcomes After PCI With DES in Relation to CAD Complexity

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content